Healthcare Partners Accredi... Net Worth

The estimated Net Worth of Healthcare Partners Accredi... is at least $1.92 Milliarde dollars as of 29 July 2014. Healthcare Accredi owns over 380,867 units of Pfenex stock worth over $1,920,974,173 and over the last 10 years Healthcare sold PFNX stock worth over $118,069.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Healthcare Accredi PFNX stock SEC Form 4 insiders trading

Healthcare has made over 1 trades of the Pfenex stock since 2014, according to the Form 4 filled with the SEC. Most recently Healthcare sold 380,867 units of PFNX stock worth $118,069 on 29 July 2014.

The largest trade Healthcare's ever made was selling 380,867 units of Pfenex stock on 29 July 2014 worth over $118,069. On average, Healthcare trades about 380,867 units every 0 days since 2014. As of 29 July 2014 Healthcare still owns at least 3,395,147 units of Pfenex stock.

You can see the complete history of Healthcare Accredi stock trades at the bottom of the page.

What's Healthcare Accredi's mailing address?

Healthcare's mailing address filed with the SEC is 152 W 57, 19TH FLOOR152 W 57TH STREET, 19TH FLOOR, , NEW YORKNEW YORK, NYNY, 1001910019.

Insiders trading at Pfenex

Over the last 10 years, insiders at Pfenex have traded over $99,496,796 worth of Pfenex stock and bought 36,000 units worth $174,640 . The most active insiders traders include Chemical Co /De/ Dow, James C Gale und Healthcare Partners Accredi.... On average, Pfenex executives and independent directors trade stock every 46 days with the average trade being worth of $90,240,574. The most recent stock trade was executed by Asset Management Lpweiss An... on 29 September 2020, trading 100,000 units of PFNX stock currently worth $1,274,000.

What does Pfenex do?

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Complete history of Healthcare Accredi stock trades at Pfenex

Pfenex executives and stock owners

Pfenex executives and other stock owners filed with the SEC include:

• Shawn Scranton,
  Chief Operating Officer
• Susan A. Knudson,
  Chief Financial Officer
• Evert B. Schimmelpennink,
  See Remarks
• Patricia Lady,
  Chief Accounting Officer
• Jason Grenfell Gardner,
  Director
• Martin Brenner,
  Chief Scientific Officer
• Magda Marquet,
  Director
• Phillip M Schneider,
  Director
• Sigurdur O Olafsson,
  Director
• Hubert C Chen,
  Chief Medical Officer
• John Mack Taylor,
  Director
• Patrick K. Lucy,
  Chief Business Officer
• Robin Campbell,
  Director
• Lorianne Masuoka,
  Director
• Dennis M Fenton,
  Director
• William R Rohn,
  Director
• Henry W. Jr. Talbot,
  VP of Research & Operations
• Healthcare Partners Accredi...,
  10% owner
• Bertrand C. Liang,
  Chief Executive Officer
• Steven S. Sr. Sandoval,
  Chief Manufacturing Officer
• Paul A. Wagner,
  Chief Financial Officer
• Chemical Co /De/ Dow,
  10% owner
• Healthcare Partners Accredi...,
  
• James C Gale,
  Director
• Asset Management Lpweiss An...,
  
• Management, Llc Newtyn,
  10% owner